Get started
Author

Laura Ordóñez-Boschetti

Observed names: L Ordoñez-Boschetti, L. Ordoñez-Boschetti, Laura Ordoñez Boschetti, Laura Ordoñez-Boschetti
Institution: Hospital Español
Observed institution: Hospital Español
OpenAlex ID: A5022324355
Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study
2015 · Laura Ordoñez-Boschetti, Roberto Rey, et al. · Advances in Therapy · 22
PDF
Disease-modifying therapies in multiple sclerosis in Latin America
2017 · Eli Skromne-Eisenberg, Laura Ordoñez-Boschetti, et al. · Multiple Sclerosis Journal - Experimental Translational and Clinical · 11
Síndrome de encefalopatía posterior reversible (PRES) asociado a SARS-CoV-2. Reporte de caso
2020 · L. Ordoñez-Boschetti, C.M. Torres-Romero, et al. · Neurología · 8
PDF
[Associated posterior reversible encephalopathy syndrome (PRES) to SARS-CoV-2. Case report].
2021 · L Ordoñez-Boschetti, C M Torres-Romero, et al. · PubMed · 6
Clinical practice patterns in multiple sclerosis management: Mexican consensus recommendations
2021 · Eli Skromne-Eisenberg, Irene Treviño-Frenk, et al. · Multiple Sclerosis and Related Disorders · 5
Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
2026 · Andreu Vilaseca, Philippe A. Bilodeau, et al. · JAMA Neurology · 4
Associated posterior reversible encephalopathy syndrome (PRES) to SARS-CoV-2. Case report
2020 · L. Ordoñez-Boschetti, C.M. Torres-Romero, et al. · Neurología (English Edition) · 4
PDF
Guía de práctica clínica MEXCTRIMS para el diagnóstico y el tratamiento de la esclerosis múltiple en México. Parte I
2025 · Gloria de L. Llamosa-García-Velázquez, Nayeli A. Sánchez-Rosales, et al. · Gaceta Médica de México · 1
PDF
Erratum to: Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study
2015 · Laura Ordoñez-Boschetti, Roberto Rey, et al. · Advances in Therapy · 1
PDF
MEXCTRIMS clinical practice guideline for the diagnosis and treatment of multiple sclerosis in Mexico. Part II
2026 · Gloria de L. Llamosa-García-Velázquez, Nayeli A. Sánchez-Rosales, et al. · Gaceta Médica de México
PDF
MEXCTRIMS clinical practice guideline for the diagnosis and treatment of multiple sclerosis in Mexico. Part I
2026 · Gloria de L. Llamosa-García-Velázquez, Nayeli A. Sánchez-Rosales, et al. · Gaceta Médica de México
PDF
Clinical considerations on the introduction of ocrelizumab in Mexico
2020 · Laura Ordoñez-Boschetti, Merced Velázquez-Quintana, et al. · Revista de Fomento Social
PDF
Esclerosis múltiple: situación actual y tendencias futuras
2016 · Óscar Fernández, Carlos Cuevas, et al.
The real-life experience with fingolimod in Mexico: a multicenter post-marketing study
2015 · I. Treviño-Frenk, J. Flores-Rivera, et al. · Journal of the Neurological Sciences
Works count: 14
Citation count: 62
H-index: 5
I10-index: 2
Year
Topic
Type